Category Archives: Hypertension

Skip to Content Breadcrumb Trail Links "Older adults are the fastest growing group of medical cannabis users, yet evidence on cardiovascular safety for this population is scarce." Author of the article: Publishing date: A new study published in the European Journal of Internal Medicine has found that cannabis consumption among older adults with hypertension is associated with a drop in blood pressure. The study was focused on patients aged 60 or older with hypertension and a medical cannabis prescription. Researchers monitored blood pressure, blood tests, electrocardiograms (ECG) and anthropometric measurements prior to the initiation of cannabis therapy and followed up three months afterward. Continue reading →

A compelling new study, led by a team of Spanish researchers, is suggesting cardiovascular disease in mid-life is linked to neurodegeneration and cognitive decline in senior years. The research found subjects in their 50s with mild hypertension displayed evidence of impaired brain metabolism in areas associated with Alzheimers and dementia. Atherosclerosis is a common cause of cardiovascular disease, involving the slow build-up of cholesterol and fats on artery walls Continue reading →

February 16, 2021 14:30 ET | Source: Joint Commission OAKBROOK TERRACE, Ill., Feb. Continue reading →

Background: We aimed to investigate the association between morning surge (MS) of blood pressure (BP) and SYNTAX score (SS) which gives information regarding the complexity and extent of coronary artery disease (CAD) in hypertensive patients. Methods: We included 187 hypertensive patients (134 males, 53 females; mean age: 62.5 10.9 years) who underwent elective coronary angiography. Continue reading →

Hypertension, commonly known as high blood pressure, is a serious condition that can lead to cardiac arrest or heart attack, stroke, heart, kidney failure, blindness and more. South Africa has one of the highest rates of hypertension worldwide, with an estimated 6.3 million people known to be currently living with the condition thats one in three SA adults Continue reading →

When you need to whip up a quick sandwich or just have a fun and delicious way to sneak some extra protein into your diet, nothing hits the spot like some peanut butter. Everyone has come to love this spread, and we have found it goes great in dips, on top of desserts, and even makes its way into a ton of recipes thanks to its ease to cook with Continue reading →

Global high blood pressure treatment market is set to witness a substantial CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. The increased market growth can be identified by increasing number of hypertension patients. Continue reading →

Cardiovascular diseases (CVDs) have emerged to be the leading cause of death globally, claiming an estimated 17.9 million lives almost every year of which, about 6 lakh 55 thousand people die from heart disease in the United States alone. Continue reading →

Drug firm Alembic Pharmaceuticals on Friday said its arm, Alembic Global Holding SA, has received approval from the US health regulator for its generic Treprostinil injection used for the treatment of pulmonary arterial hypertension. "Alembic Global Holding SA has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Treprostinil injection, 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml (10 mg/ml), multiple-dose vials," Alembic Pharma said in a regulatory filing. The product is a generic version of United Therapeutics Corp Remodulin injection in the same strengths, it added Continue reading →

Award will help fund the development of high concentration nitric oxide (NO) for Nontuberculous Mycobacteria (NTM) pulmonary disease, which disproportionately affects cystic fibrosis (CF) patients Beyond Air recently initiated a pilot study using LungFitGO for at-home self-administration of up to 250 ppm NO to treat refractory NTM pulmonary disease in adult patients GARDEN CITY, N.Y., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc Continue reading →